Skip to main content

Table 2 Case–control analyses of ovarian and breast and ovarian cancer risk

From: Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy

   

Ovarian cancer all patients

Ovarian cancer BRCA1 -

Ovarian cancer BRCA1 +

Breast and ovarian cancer

Gene polymorphism

Genotype

Controls n(%)

n(%)

OR (±95% CI)

p

n(%)

OR (±95% CI)

p

n(%)

OR (±95% CI)

p

n(%)

OR (±95% CI)

p

PGR p.Val660Leu rs1042838

GG

239 (69.3)

143 (63.9)

1(ref)

 

131 (66.5)

1(ref)

 

12 (44.4)

1(ref)

 

46 (75.4)

1 (ref)

 

GT

95 (27.5)

74 (33.0)

1.03 (0.90-1.88)

0.160

60 (30.5)

1.15 (0.78-1.70)

0.473

14 (51.9)

2.94 (1.31-6.58)

0.009

14 (23.0)

0.77 (0.40-1.46)

0.416

TT

11 (3.2)

7 (3.1)

1.06 (0.40-2.81)

0.901

6 (3.0)

1.00 (0.36-2.75)

0.993

1 (3.70)

1.81 (0.22-15.20)

0.584

1 (1.6)

0.47 (0.06-3.75)

0.478

GT + TT

106 (30.7)

81 (36.1)

1.20 (0.88-1.63)

0.249

66 (33.5)

1.14 (0.78-1.65)

0.504

15 (55.6)

2.82 (1.28-6.23)

0.010

15 (24.6)

0.74 (0.39-1.38)

0.336

ABCB1 p.Ser893Ala p.Ser893Thr rs2032582

GG

117 (33.7)

65 (29.0)

1(ref)

 

56 (28.4)

1(ref)

 

9 (33.4)

1(ref)

 

16 (26.2)

1 (ref)

 

GT

156 (45.0)

115 (51.4)

1.33 (0.90-1.95)

0.152

104 (52.8)

1.39 (0.93-2.09)

0.108

11 (40.7)

0.92 (0.37-2.28)

0.852

33 (54.1)

1.55 (0.71-2.94)

0.184

TT

60 (17.3)

37 (16.5)

1.11 (0.67-1.85)

0.688

32 (16.3)

1.11 (0.65-1.90)

0.691

5 (18.5)

1.08 (0.35-3.38)

0.890

9 (14.8)

1.10 (0.46-2.63)

0.836

GA

9 (2.6)

2 (0.9)

0.40 (0.08-1.91)

0.250

2 (1.0)

0.46 (0.10-2.24)

0.337

--

--

--

2 (3.3)

1.63 (0.32-8.31)

0.557

TA

5 (1.4)

5 (2.2)

1.80 (0.50-6.45)

0.367

3 (1.5)

1.25 (0.29-5.49)

0.763

2 (7.4)

5.20 (0.87-31.18)

0.069

1 (1.6)

1.46 (0.16-13.6)

0.736

AA

--

--

--

--

--

--

--

--

--

--

--

--

--

GG + GT + GA

282 (81.3)

182 (81.3)

1 (ref)

 

162 (82.2)

1 (ref)

 

20 (74.1)

1 (ref)

 

51 (83.6)

1 (ref)

 

TT + TA

65 (18.7)

42 (18.7)

1.00 (0.92-1.09)

1.000

35 (17.8)

0.94 (0.60-1.48)

0.780

7 (25.9)

1.52 (0.61-3.76)

0.364

10 (16.4)

0.85 (0.41-1.77)

0.664

ABCB1 p.Ile1145= rs1045642

CC

83 (24.0)

44 (19.6)

1(ref)

 

35 (17.8)

1(ref)

 

9 (33.3)

1(ref)

 

16 (26.2)

1 (ref)

 

CT

162 (47.0)

122 (54.5)

1.42 (0.92-2.19)

0.113

112 (56.8)

1.64 (1.03-2.60)

0.036

10 (37.1)

0.57 (0.22-1.46)

0.239

26 (42.6)

0.83 (0.42-1.64)

0.596

TT

100 (29.0)

58 (25.9)

1.09 (0.67-1.78)

0.718

50 (25.4)

1.18 (0.70-2.00)

0.522

8 (29.6)

0.74 (0.27-2.00)

0.549

19 (31.2)

0.98 (0.48-2.04)

0.969

CT + TT

262 (76.0)

180 (80.4)

1.02 (0.81-1.30)

0.827

162 (82.2)

1.47 (0.94-2.28)

0.089

18 (66.7)

0.63 (0.27-1.46)

0.285

45 (73.8)

0.89 (0.48-1.66)

0.716

ABCG2 p.Gln141Lys rs2231142

CC

276 (80.2)

191 (86.4)

1 (ref)

 

167 (85.6)

1 (ref)

 

24 (92.3)

1 (ref)

 

56 (87.5)

1 (ref)

 

CA

68 (19.8)

30 (13.6)

0.64 (0.40-1.02)

0.059

28 (14.4)

0.68 (0.42–1.10)

0.116

2 (7.7)

0.34 (0.08–0.47)

0.147

8 (12.5)

0.58 (0.26–1.28)

0.175

ATM p.Asp1853Asn rs1801516

GG

254 (75.8)

153 (68.6)

1 (ref)

 

134 (68.4)

1 (ref)

 

19 (70.4)

1 (ref)

 

45 (70.3)

1 (ref)

 

GA

76 (22.7)

64 (28.7)

1.40 (0.95-2.06)

0.091

57 (29.1)

1.42 (0.95-2.13)

0.083

7 (25.9)

1.23 (0.50-3.05)

0.651

15 (23.4)

1.11 (0.59-2.11)

0.740

AA

5 (1.5)

6 (2.7)

1.99 (0.60-6.66)

0.262

5 (2.5)

1.90 (0.54-6.69)

0.319

1 (3.7)

2.67 (0.39-24.29)

0.380

4 (6.3)

4.52 (1.16-17.56)

0.029

GA + AA

81 (24.2)

70 (31.4)

1.43 (0.98-2.09)

0.061

62 (31.6)

1.45 (0.98-2.15)

0.062

8 (29.6)

1.32 (0.73-2.40)

0.352

19 (29.7)

1.32 (0.56-3.14)

0.528

TP53 p.Arg72Pro rs1042522

GG

167 (49.0)

130 (57.8)

1 (ref)

 

115 (58.1)

1 (ref)

 

15 (55.6)

1 (ref)

 

29 (48.3)

1 (ref)

 

GC

150 (44.0)

79 (35.1)

0.68 (0.47-0.97)

0.031

70 (35.3)

0.68 (0.47-0.98)

0.039

9 (33.3)

0.67 (0.28-1.57)

0.355

29 (48.3)

1.11 (0.64-1.95)

0.707

CC

24 (7.0)

16 (7.1)

0.86 (0.44-1.68)

0.652

13 (6.6)

0.79 (0.39-1.61)

0.511

3 (11.1)

1.39 (0.38-5.16)

0.621

2 (3.3)

0.48 (0.11-2.14)

0.336

GC + CC

174 (51.0)

95 (42.2)

0.80 (0.61-1.05)

0.104

83 (41.9)

0.69 (0.49-0.99)

0.042

12 (44.4)

0.77 (0.35-1.69)

0.511

31 (51.67)

1.03 (0.59-1.78)

0.927

ATP7B p.Ser406Ala rs1801243

TT

103 (30.8)

41 (19.0)

1 (ref)

 

35 (18.5)

1 (ref)

 

6 (22.2)

1 (ref)

 

13 (20.3)

1 (ref)

 

TG

157 (47.0)

113 (52.3)

1.81 (1.17-2.80)

0.008

100 (52.9)

1.87 (1.18-2.97)

0.007

13 (48.2)

1.42 (0.52-3.88)

0.490

32 (50.0)

1.61 (0.81-3.23)

0.174

GG

74 (22.2)

62 (28.7)

2.10 (1.28-3.46)

0.003

54 (28.6)

2.15 (1.27-3.62)

0.004

8 (29.6)

1.86 (0.61-5.61)

0.270

19 (29.7)

2.03 (0.94-4.40)

0.069

TG + GG

231 (69.2)

175 (81.0)

1.90 (1.26-2.88)

0.002

154 (81.5)

1.96 (1.27-3.03)

0.002

21 (77.8)

1.56 (0.61-3.99)

0.352

51 (79.7)

1.75 (0.91-3.36)

0.093

ATP7B p.Arg952Lys rs732774

AA

103 (30.7)

86 (38.9)

1 (ref)

 

76 (39.2)

1 (ref)

 

10 (37.0)

1 (ref)

 

25 (39.7)

1 (ref)

 

AG

159 (47.5)

96 (43.4)

0.72 (0.49-1.06)

0.096

82 (42.3)

0.70 (0.47-1.04)

0.078

14 (51.9)

0.91 (0.39-2.11)

0.821

31 (49.2)

0.80 (0.45-1.44)

0.471

GG

73 (21.8)

39 (17.7)

0.64 (0.39-1.04)

0.070

36 (18.5)

0.67 (0.41-1.10)

0.112

3 (11.1)

0.42 (0.11-1.61)

0.203

7 (11.1)

0.40 (0.16-0.97)

0.041

AG + GG

232 (69.3)

135 (61.1)

0.70 (0.49-1.00)

0.047

118 (60.8)

0.69 (0.48-1.00)

0.049

17 (63.0)

0.75 (0.33-1.71)

0.499

38 (60.3)

0.67 (0.39-1.18)

0.165

GST T1/M1 Gene deletions

wt/wt

118 (34.6)

82 (36.8)

1(ref)

 

72 (36.7)

1(ref)

 

10 (37.0)

1(ref)

 

20 (31.3)

1(ref)

 

wt/null

49 (14.4)

18 (8.1)

0.53 (0.29-0.98)

0.040

17 (8.7)

0.57 (0.30-1.07)

0.076

1 (3.7)

0.24 (0.03-1.96)

0.180

6 (9.4)

0.72 (0.27-1.92)

0.512

null/wt

138 (40.5)

95 (42.6)

0.99 (0.64-1.54)

0.967

82 (41.8)

0.97 (0.65-0.47)

0.90

13 (48.2)

1.11 (0.47-2.64)

0.810

31 (48.4)

1.32 (0.72-2.45)

0.368

null/null

36 (10.5)

28 (12.5)

1.12 (0.63-1.98)

0.698

25 (12.8)

1.14 (0.63-2.06)

0.667

3 (11.1)

0.98 (0.24-4.04)

0.982

7 (10.9)

1.14 (0.45-2.95)

0.774

GSTP1 p.Ile105Val rs1695

AA

151 (45.2)

104 (46.4)

1 (ref)

 

93 (47.2)

1 (ref)

 

11 (40.7)

1 (ref)

 

32 (52.4)

1 (ref)

 

AG

162 (48.5)

95 (42.4)

0.85 (0.60-1.22)

0.376

84 (42.6)

0.84 (0.58-1.22)

0.361

11 (40.7)

0.93 (0.39-2.22)

0.873

36 (36.1)

0.64 (0.36-1.15)

0.137

GG

21 (6.3)

25 (11.2)

1.73 (0.92-3.26)

0.090

20 (10.2)

1.54 (0.79-3.01)

0.199

5 (18.6)

3.27 (1.03-10.42)

0.044

7 (11.5)

1.57 (0.61-4.03)

0.342

AG + GG

183 (54.8)

120 (53.6)

0.95 (0.68-1.34)

0.776

104 (52.8)

0.92 (0.65-1.32)

0.656

16 (49.3)

1.20 (0.54-2.67)

0.653

43 (47.6)

0.75 (0.43-1.29)

0.296

  1. Statistically significant analyses are in bold.